Discover Data,
Develop Insights, Deliver Value

It’s what we do best

Services

Premier services that lead to better, faster decisions, customized solutions, and successful partnerships.

Data

In-house and commercially-available data to meet your needs.

Publications

Over 900 peer-reviewed publications in dozens of therapeutic areas!

Publication

Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017

Oncologist
Javle M, Lee S, Azad NS, Borad MJ, et al. Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017. Oncologist. 2022 Aug 16.

Read now
Blog

Quarterly Newsletter – RWD Insights & Custom Registry

Get the latest news and highlights for more about conferences, RWD, and evidence generation.

Read now
Blog

FAQs: Real-World Questions, Answered.

Read now

Schedule Your
Consultation Today




    The amazing research collaboration between STATinMED and our team has already led to a comprehensive body of evidence to inform confident decision-making for many patients.

    Joint Partnership Alliance

    Real-World Evidence Executive

    The abstract has been accepted as a podium presentation at ISPOR! Many thanks to the team for all the hard work over the last several months!

    HEOR Executive

    global biopharmaceutical company

    The abstract has been accepted as a podium presentation at ISPOR! Many thanks to the team for all the hard work over the last several months!

    HEOR Executive

    global biopharmaceutical company

    Let’s give kudos to ourselves for everything we have accomplished together. Please share with STATinMED colleagues involved in the study–let them know our deep appreciation for all of them.

    Real-World Evidence Executive

    Joint Partnership Alliance

    On behalf of our study team, I would like to thank you all for your tremendous help on the study. Acceptance by Stroke is a watershed moment for the Real-World Data program.

    Real-World Evidence Executive, Joint Partnership Alliance

    two global biopharmaceutical companies